In this report, we demonstrate that SHP2 binds to KIT mutants and the proliferative signal from oncogenic KIT is transduced to the MAPK/ERK pathway via SHP2 in KIT‐mutant GIST. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.